Each hospitalization was evaluated as a possible index event leading to a readmission. ... Factors associated with 30-day readmission rates were also examined. The study results were published online Aug.
Researchers used 2013 and 2014 data from the Healthcare Cost and Utilization's all-payer Nationwide Readmission Database to compare hospital-level 30-day readmissions for the conditions that are publicly ... a program to reduce readmissions should be
Excess readmission ratio (ERR), the performance measure used by CMS as part of its Hospital Readmissions Reduction Program, is not associated with improved care quality or long-term clinical outcomes after ... June 30, 2011 (the time period used to
The study looked at 993 readmissions at 12 U.S. academic medical centers. ... Our findings may reflect the lack of a clear and objective answer regarding what caused a readmission in most cases, as well as the multifactorial nature of readmissions,”
Researchers have developed two models to predict patients' risk of readmission within 30 days of percutaneous coronary intervention (PCI). ... The models could help clinicians and hospitals risk-stratify patients by readmission risk and potentially
The researchers estimated national, regional and hospital-level preventable readmission rates, as well as patient-level factors associated with preventable readmissions. ... Of all readmissions, 11.9% were for a preventable cause. When all discharges
The risk continued postdischarge, with patients who had detectable or elevated troponin during hospitalization having more than double the risk of mortality and readmission in the next 6 months (mortality OR, ... 2.11; 95% CI, 1.43 to 3.12; combined
1, 2017, issue. Photo by Thinkstock. The patients who took bezlotoxumab had a significantly lower rate of CDI-associated readmissions in the 30 days after discharge (absolute difference, 6.1%; 95% ... They found reductions in CDI-associated readmissions
The primary outcomes were changes in length of stay and 30-day readmissions, compared among patients at the intervention site and the control site before and after the intervention. ... The intervention was not associated with any significant differences
The average length of stay was 2.7 days, and the readmission rate was 26.5%. ... 3.4 days; P=0.09), and readmission rates did not differ (26.5% vs.